{"count": 5, "results": [{"_id": "27521968", "pmid": 27521968, "title": "Acute and Chronic Pretreatment With Atenolol Attenuates Intestinal Ischemia and Reperfusion Injury in Hypercholesterolemic Rats.", "journal": "J Cardiothorac Vasc Anesth", "authors": ["Öztürk T", "Vural K", "Tuğlu İ", "Var A", "Kurdal T", "Aydemir I"], "date": "2016-08-01T00:00:00Z", "doi": "10.1053/j.jvca.2016.03.140", "meta_date_publication": "2016 Aug", "meta_volume": "30", "meta_issue": "4", "meta_pages": "985-92", "score": 50070.34, "text_hl": "Acute and Chronic Pretreatment With @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ Attenuates @DISEASE_Intestinal_Diseases @DISEASE_MESH:D007410 @@@Intestinal Ischemia@@@ and Reperfusion Injury in @<m>DISEASE_Hyperlipoproteinemia_Type_II</m> @DISEASE_MESH:D006938 @@@Hypercholesterolemic@@@ @SPECIES_10116 @@@Rats@@@.", "citations": {"NLM": "Öztürk T, Vural K, Tuğlu İ, Var A, Kurdal T, Aydemir I. Acute and Chronic Pretreatment With Atenolol Attenuates Intestinal Ischemia and Reperfusion Injury in Hypercholesterolemic Rats. J Cardiothorac Vasc Anesth. 2016 Aug;30(4):985-92. PMID: 27521968", "BibTeX": "@article{27521968, title={Acute and Chronic Pretreatment With Atenolol Attenuates Intestinal Ischemia and Reperfusion Injury in Hypercholesterolemic Rats.}, author={Öztürk T and Vural K and Tuğlu İ and Var A and Kurdal T and Aydemir I}, journal={J Cardiothorac Vasc Anesth}, volume={30}, number={4}, pages={985-92}}"}}, {"_id": "2905683", "pmid": 2905683, "title": "The influence of atenolol and prazosin on serum lipids and atherosclerosis in minipigs fed a hyperlipidemic diet.", "journal": "Gen Pharmacol", "authors": ["Nafstad I", "Tollersrud S", "Eriksen K", "Helgeland A", "Solberg LA", "Bredesen J", "Dale O"], "date": "1988-01-01T00:00:00Z", "doi": "10.1016/0306-3623(88)90135-8", "meta_date_publication": "1988", "meta_volume": "19", "meta_issue": "5", "meta_pages": "719-24", "score": 50062.914, "text_hl": "The effect of the adrenergic blockers @CHEMICAL_Prazosin @CHEMICAL_MESH:D011224 @@@prazosin@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ were tested in @<m>DISEASE_Hyperlipoproteinemia_Type_II</m> @DISEASE_MESH:D006938 @@@hypercholesterolemic@@@ Gottingen minipigs. 2. ", "citations": {"NLM": "Nafstad I, Tollersrud S, Eriksen K, Helgeland A, Solberg LA, Bredesen J, Dale O. The influence of atenolol and prazosin on serum lipids and atherosclerosis in minipigs fed a hyperlipidemic diet. Gen Pharmacol. 1988;19(5):719-24. PMID: 2905683", "BibTeX": "@article{2905683, title={The influence of atenolol and prazosin on serum lipids and atherosclerosis in minipigs fed a hyperlipidemic diet.}, author={Nafstad I and Tollersrud S and Eriksen K and Helgeland A and Solberg LA and Bredesen J and Dale O}, journal={Gen Pharmacol}, volume={19}, number={5}, pages={719-24}}"}}, {"_id": "9082374", "pmid": 9082374, "title": "[Comparative effects of captopril and atenolol on lipid metabolism in hypertensive hypercholesterolemic patients treated with pravastatin. A multicenter controlled trial].", "journal": "Presse Med", "authors": ["Witchitz S", "Provendier O", "Arsenescu I"], "date": "1996-12-21T00:00:00Z", "meta_date_publication": "1996 Dec 21", "meta_volume": "25", "meta_issue": "40", "meta_pages": "2013-6", "score": 50060.48, "text_hl": "[Comparative effects of @CHEMICAL_Captopril @CHEMICAL_MESH:D002216 @@@captopril@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ on @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ metabolism in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @<m>DISEASE_Hyperlipoproteinemia_Type_II</m> @DISEASE_MESH:D006938 @@@hypercholesterolemic@@@ @SPECIES_9606 @@@patients@@@ treated with @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@. ", "citations": {"NLM": "Witchitz S, Provendier O, Arsenescu I. [Comparative effects of captopril and atenolol on lipid metabolism in hypertensive hypercholesterolemic patients treated with pravastatin. A multicenter controlled trial]. Presse Med. 1996 Dec 21;25(40):2013-6. PMID: 9082374", "BibTeX": "@article{9082374, title={[Comparative effects of captopril and atenolol on lipid metabolism in hypertensive hypercholesterolemic patients treated with pravastatin. A multicenter controlled trial].}, author={Witchitz S and Provendier O and Arsenescu I}, journal={Presse Med}, volume={25}, number={40}, pages={2013-6}}"}}, {"_id": "8011003", "pmid": 8011003, "title": "Studies on the glycemic and lipidemic effect of atenolol and propranolol in normal and diabetic rats.", "journal": "Arzneimittelforschung", "authors": ["Gaafar K", "Salama S", "el Batran S"], "date": "1994-04-01T00:00:00Z", "meta_date_publication": "1994 Apr", "meta_volume": "44", "meta_issue": "4", "meta_pages": "496-501", "score": 50058.59, "text_hl": "This effect was masked when @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ was administered concurrently with @CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glibenclamide@@@, but a @<m>DISEASE_Hyperlipoproteinemia_Type_II</m> @DISEASE_MESH:D006938 @@@hypercholesterolemic@@@ effect (p < 0.01) was noticed. ", "citations": {"NLM": "Gaafar K, Salama S, el Batran S. Studies on the glycemic and lipidemic effect of atenolol and propranolol in normal and diabetic rats. Arzneimittelforschung. 1994 Apr;44(4):496-501. PMID: 8011003", "BibTeX": "@article{8011003, title={Studies on the glycemic and lipidemic effect of atenolol and propranolol in normal and diabetic rats.}, author={Gaafar K and Salama S and el Batran S}, journal={Arzneimittelforschung}, volume={44}, number={4}, pages={496-501}}"}}, {"_id": "24452083", "pmid": 24452083, "title": "Anti-sympathetic action enhances statin's pleiotropic effects: the combined effect of rosuvastatin and atenolol on endothelial function.", "journal": "Int Angiol", "authors": ["Takase B", "Hattori H", "Tanaka Y", "Nagata M", "Ishihara M"], "date": "2014-02-01T00:00:00Z", "meta_date_publication": "2014 Feb", "meta_volume": "33", "meta_issue": "1", "meta_pages": "27-34", "score": 50056.74, "text_hl": "METHODS: FMD and NMD were measured using the UNEXEF18G before and after 4-week treatment of @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ (5 mg/day) with or without @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (25 mg/day) in 44 @<m>DISEASE_Hyperlipoproteinemia_Type_II</m> @DISEASE_MESH:D006938 @@@hypercholesterolemic@@@ @SPECIES_9606 @@@patients@@@ (70+-8 years old, LDL-C >140 mg/dL) with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@. ", "citations": {"NLM": "Takase B, Hattori H, Tanaka Y, Nagata M, Ishihara M. Anti-sympathetic action enhances statin's pleiotropic effects: the combined effect of rosuvastatin and atenolol on endothelial function. Int Angiol. 2014 Feb;33(1):27-34. PMID: 24452083", "BibTeX": "@article{24452083, title={Anti-sympathetic action enhances statin's pleiotropic effects: the combined effect of rosuvastatin and atenolol on endothelial function.}, author={Takase B and Hattori H and Tanaka Y and Nagata M and Ishihara M}, journal={Int Angiol}, volume={33}, number={1}, pages={27-34}}"}}]}